| Kayla Williams, | |
|
1660 E Booker Dairy Rd, Smithfield, NC 27577-9405 | |
| (919) 938-3824 | |
| Not Available |
| Full Name | Kayla Williams |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1660 E Booker Dairy Rd, Smithfield, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205476447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 13889 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kayla Williams, 1660 E Booker Dairy Rd, Smithfield, NC 27577-9405 Ph: () - | Kayla Williams, 1660 E Booker Dairy Rd, Smithfield, NC 27577-9405 Ph: (919) 938-3824 |
News Archive
Health-conscious people know that high levels of total cholesterol and LDL cholesterol (the so-called "bad" cholesterol) can increase the risk of heart attacks. Now scientists are reporting that another form of cholesterol called oxycholesterol - virtually unknown to the public - may be the most serious cardiovascular health threat of all. Scientists from China presented one of the first studies on the cholesterol-boosting effects of oxycholesterol here today at the 238th National Meeting of the American Chemical Society. The researchers hope their findings raise public awareness about oxycholesterol, including foods with the highest levels of the substance and other foods that can combat oxycholesterol's effects.
Arcion Therapeutics, a venture backed clinical stage biotechnology company developing topical therapies for chronic pain, today announced top-line results from a successful Phase 2b double-blind, randomized, placebo-controlled clinical trial of its lead topical pain candidate, ARC-4558, in adult patients with painful diabetic neuropathy (PDN). Arcion recently held an End of Phase 2 meeting with the United States Food and Drug Administration (FDA) and the ARC-4558 program is now poised to enter Phase 3 studies.
Results from the first phase 1 trial of an Ebola vaccine based on the current (2014) strain of the virus are today published in The Lancet. Until now, all tested Ebola virus vaccines have been based on the virus strain from the Zaire outbreak in 1976. The results suggest that the new vaccine is safe, and provokes an immune response in recipients, although further long-term testing will be needed to establish whether it can protect against the Ebola virus.
Australian researchers have called for additional services for survivors of intimate partner violence - warning those who have these experiences are more vulnerable to elder abuse.
A recent study provides an assessment of the ongoing pandemic by estimating excess deaths in Sweden, Switzerland, and Spain.
› Verified 3 days ago
Alexis Sanders, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1660 E Booker Dairy Rd, Smithfield, NC 27577 Phone: 919-938-3824 | |
Sara Spridgen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1660 E Booker Dairy Rd, Smithfield, NC 27577 Phone: 919-938-3824 | |
Isidora Nichols, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1660 E Booker Dairy Rd, Smithfield, NC 27577 Phone: 919-938-3824 | |
Zoe Lucrezia Nelson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 447 Venture Dr, Smithfield, NC 27577 Phone: 910-298-2331 | |
Kayla Gallelli, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1660 E Booker Dairy Rd, Smithfield, NC 27577 Phone: 919-938-3824 | |
Miss Riley Marie Thomas, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1660 E Booker Dairy Rd, Smithfield, NC 27577 Phone: 919-938-3824 | |
Dominique Haynes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1660 E Booker Dairy Rd, Smithfield, NC 27577 Phone: 919-938-3824 |